Projected Income Statement: CSL Limited

Forecast Balance Sheet: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 -779 10,679 10,526 8,981 9,383 9,177 8,856 8,363
Change - 1,470.86% -1.43% -14.68% 4.48% -2.2% -3.5% -5.57%
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 1,079 1,228 849 636 646 912.4 1,013 1,036
Change - 13.83% -30.86% -25.09% 1.57% 41.23% 11% 2.28%
Free Cash Flow (FCF) 1 1,550 1,373 1,915 2,925 2,866 3,129 2,940 3,097
Change - -11.41% 39.48% 52.74% -2.02% 9.18% -6.04% 5.35%
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 34.04% 29.3% 32.09% 33.11% 28.09% 32.29% 32.68% 32.95%
EBIT Margin (%) 27.72% 23.06% 25.76% 28.72% 29.25% 27.82% 28.24% 28.46%
EBT Margin (%) 26.32% 20.01% 22.8% 23.94% -25.87% 23.44% 25.2% 25.53%
Net margin (%) 21.35% 16.48% 17.85% 19.3% -16.33% 17.91% 19.37% 19.76%
FCF margin (%) 14.67% 10.32% 12.94% 18.8% 18.14% 19.85% 18.02% 18.21%
FCF / Net Income (%) 68.74% 62.58% 72.48% 97.44% -111.13% 110.83% 93.07% 92.18%

Profitability

        
ROA 9.7% 6.79% 7.12% 7.75% -7.06% 10.32% 10.48% 10.63%
ROE 19.64% 14.45% 15.94% 16.36% -15.11% 19.14% 18.79% 18.51%

Financial Health

        
Leverage (Debt/EBITDA) - 2.74x 2.22x 1.74x 2.11x 1.8x 1.66x 1.49x
Debt / Free cash flow - 7.78x 5.5x 3.07x 3.27x 2.93x 3.01x 2.7x

Capital Intensity

        
CAPEX / Current Assets (%) 10.21% 9.23% 5.74% 4.09% 4.09% 5.79% 6.21% 6.09%
CAPEX / EBITDA (%) 30% 31.49% 17.87% 12.35% 14.56% 17.92% 19% 18.49%
CAPEX / FCF (%) 69.6% 89.44% 44.33% 21.74% 22.54% 29.16% 34.45% 33.44%

Items per share

        
Cash flow per share 1 5.592 5.375 5.697 7.324 7.287 7.369 7.988 8.45
Change - -3.87% 5.98% 28.56% -0.51% 1.13% 8.4% 5.78%
Dividend per Share 1 2.22 2.36 2.64 2.92 2.92 3.002 3.185 3.414
Change - 6.31% 11.86% 10.61% 0% 2.8% 6.1% 7.19%
Book Value Per Share 1 30.26 32.73 35.93 39.93 30.9 33.71 36.69 40.18
Change - 8.14% 9.79% 11.14% -22.62% 9.11% 8.82% 9.52%
EPS 1 4.8 4.53 5.45 6.17 -5.35 6.073 6.716 7.055
Change - -5.62% 20.31% 13.21% -186.71% 213.52% 10.59% 5.04%
Nbr of stocks (in thousands) 481,706 482,372 483,253 484,212 478,912 478,912 478,912 478,912
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD
Estimates
2027 *2028 *
P/E 20.6x 18.6x
PBR 3.7x 3.4x
EV / Sales 4.37x 4.21x
Yield 2.4% 2.55%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
124.82USD
Average target price
126.29USD
Spread / Average Target
+1.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CSL Stock
  4. Financials CSL Limited
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!